Cargando…

Flipping the dogma – phosphatidylserine in non-apoptotic cell death

ABSTRACT: The exposure of phosphatidylserine (PS) on the outer plasma membrane has long been considered a unique feature of apoptotic cells. Together with other “eat me” signals, it enables the recognition and phagocytosis of dying cells (efferocytosis), helping to explain the immunologically-silent...

Descripción completa

Detalles Bibliográficos
Autores principales: Shlomovitz, Inbar, Speir, Mary, Gerlic, Motti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819419/
https://www.ncbi.nlm.nih.gov/pubmed/31665027
http://dx.doi.org/10.1186/s12964-019-0437-0
_version_ 1783463725287604224
author Shlomovitz, Inbar
Speir, Mary
Gerlic, Motti
author_facet Shlomovitz, Inbar
Speir, Mary
Gerlic, Motti
author_sort Shlomovitz, Inbar
collection PubMed
description ABSTRACT: The exposure of phosphatidylserine (PS) on the outer plasma membrane has long been considered a unique feature of apoptotic cells. Together with other “eat me” signals, it enables the recognition and phagocytosis of dying cells (efferocytosis), helping to explain the immunologically-silent nature of apoptosis. Recently, however, PS exposure has also been reported in non-apoptotic forms of regulated inflammatory cell death, such as necroptosis, challenging previous dogma. In this review, we outline the evidence for PS exposure in non-apoptotic cells and extracellular vesicles (EVs), and discuss possible mechanisms based on our knowledge of apoptotic-PS exposure. In addition, we examine the outcomes of non-apoptotic PS exposure, including the reversibility of cell death, efferocytosis, and consequent inflammation. By examining PS biology, we challenge the established approach of distinguishing apoptosis from other cell death pathways by AnnexinV staining of PS externalization. Finally, we re-evaluate how PS exposure is thought to define apoptosis as an immunologically silent process distinct from other non-apoptotic and inflammatory cell death pathways. Ultimately, we suggest that a complete understanding of how regulated cell death processes affect the immune system is far from being fully elucidated. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-6819419
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68194192019-10-31 Flipping the dogma – phosphatidylserine in non-apoptotic cell death Shlomovitz, Inbar Speir, Mary Gerlic, Motti Cell Commun Signal Review ABSTRACT: The exposure of phosphatidylserine (PS) on the outer plasma membrane has long been considered a unique feature of apoptotic cells. Together with other “eat me” signals, it enables the recognition and phagocytosis of dying cells (efferocytosis), helping to explain the immunologically-silent nature of apoptosis. Recently, however, PS exposure has also been reported in non-apoptotic forms of regulated inflammatory cell death, such as necroptosis, challenging previous dogma. In this review, we outline the evidence for PS exposure in non-apoptotic cells and extracellular vesicles (EVs), and discuss possible mechanisms based on our knowledge of apoptotic-PS exposure. In addition, we examine the outcomes of non-apoptotic PS exposure, including the reversibility of cell death, efferocytosis, and consequent inflammation. By examining PS biology, we challenge the established approach of distinguishing apoptosis from other cell death pathways by AnnexinV staining of PS externalization. Finally, we re-evaluate how PS exposure is thought to define apoptosis as an immunologically silent process distinct from other non-apoptotic and inflammatory cell death pathways. Ultimately, we suggest that a complete understanding of how regulated cell death processes affect the immune system is far from being fully elucidated. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2019-10-29 /pmc/articles/PMC6819419/ /pubmed/31665027 http://dx.doi.org/10.1186/s12964-019-0437-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Shlomovitz, Inbar
Speir, Mary
Gerlic, Motti
Flipping the dogma – phosphatidylserine in non-apoptotic cell death
title Flipping the dogma – phosphatidylserine in non-apoptotic cell death
title_full Flipping the dogma – phosphatidylserine in non-apoptotic cell death
title_fullStr Flipping the dogma – phosphatidylserine in non-apoptotic cell death
title_full_unstemmed Flipping the dogma – phosphatidylserine in non-apoptotic cell death
title_short Flipping the dogma – phosphatidylserine in non-apoptotic cell death
title_sort flipping the dogma – phosphatidylserine in non-apoptotic cell death
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819419/
https://www.ncbi.nlm.nih.gov/pubmed/31665027
http://dx.doi.org/10.1186/s12964-019-0437-0
work_keys_str_mv AT shlomovitzinbar flippingthedogmaphosphatidylserineinnonapoptoticcelldeath
AT speirmary flippingthedogmaphosphatidylserineinnonapoptoticcelldeath
AT gerlicmotti flippingthedogmaphosphatidylserineinnonapoptoticcelldeath